Relationship of lipoprotein-associated phospholipase A2 and oxidized low density lipoprotein in carotid atherosclerosis

Journal of Lipid Research

Volumn 50, Issue 9, 2009, Pages 1735-1743

  Vickers, Kasey C ^a   Maguire, Colin T ^a   Wolfert, Robert ^b   Burns, Alan R ^a   Reardon, Michael ^c   Geis, Richard ^c   Holvoet, Paul ^d   Morrisett, Joel D ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b diaDexus Inc   (United States)

^c HOUSTON METHODIST HOSPITAL   (United States)

^d UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Atherosclerotic plaque; Carotid endarterectomy; Lysophosphatidylcholine; Risk factors

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; OXIDIZED LOW DENSITY LIPOPROTEIN;

ARTICLE; ATHEROGENESIS; ATHEROMA; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY BIFURCATION; CAROTID ARTERY DISEASE; CAROTID ENDARTERECTOMY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME BLOOD LEVEL; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERNAL CAROTID ARTERY; LIPOPROTEIN BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN FUNCTION; TISSUE DISTRIBUTION;

1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; AGED; ATHEROSCLEROSIS; BIOLOGICAL TRANSPORT; CAROTID ARTERIES; CAROTID ARTERY DISEASES; ENDARTERECTOMY, CAROTID; FEMALE; HUMANS; LIPOPROTEINS, LDL; MALE;

EID: 70350367731     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M800342-JLR200     Document Type: Article

References (41)

1. Wu, J. T., and L. L. Wu. 2006. Linking inflammation and atherogenesis: soluble markers identified for detection of risk factors and for early risk assessment. Clin. Chim. Acta. 366: 74-80.
2. Ross, R. 1999. Atherosclerosis: an inflammatory disease. N. Engl. J. Med. 340: 115-126.
3. Hazen, S. L. 2008. Oxidized phospholipids as endogenous pattern recognition ligands in innate immunity. J. Biol. Chem. 283: 15527-15531.
4. Witztum, J. L., and D. Steinberg. 1991. Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 88: 1785-1792.
5. Steinberg, D. 1997. Low-density lipoprotein oxidation and its pathobiological significance. J. Biol. Chem. 272: 20963-20966.
6. Heinecke, J. W. 1998. Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low-density lipoprotein hypothesis. Atherosclerosis. 141: 1-15.
7. Hulthe, J., and B. Fagerberg. 2002. Circulating oxidized LDL is associated with subclinical atherosclerosis development and inflammatory cytokines (AIR Study). Arterioscler. Thromb. Vasc. Biol. 22: 1162-1167.
8. Sigurdardottir, V., B. Fagerberg, and J. Hulthe. 2002. Circulating oxidized low-density lipoprotein (LDL) is associated with risk factors of the metabolic syndrome and LDL size in clinically healthy 58-year-old men (AIR study). J. Intern. Med. 252: 440-447.
9. Toshima, S., A. Hasegawa, M. Kurabayashi, H. Itabe, T. Takano, J. Sugano, K. Shimamura, J. Kimura, I. Michishita, T. Suzuki, et al. 2000. Circulating oxidized low density lipoprotein levels: a biochemical risk marker for coronary heart disease. Arterioscler. Thromb. Vasc. Biol. 20: 2243-2247.
10. Holvoet, P., and D. Collen. 1998. Oxidation of low density lipoproteins in the pathogenesis of atherosclerosis. Atherosclerosis. 137: S33-S38.
11. Tokumura, A., M. Toujima, Y. Yoshioka, and K. Fukuzawa. 1996. Lipid peroxidation in low density lipoproteins from human plasma and egg yolk promotes accumulation of 1-acyl analogues of platelet-activating factor-like lipids. Lipids. 31: 1251-1258.
12. Stremler, K. E., D. M. Stafforini, S. M. Prescott, G. A. Zimmerman, and T. M. McIntyre. 1989. An oxidized derivative of phosphatidylcholine is a substrate for the platelet-activating factor acetylhydrolase from human plasma. J. Biol. Chem. 264: 5331-5334.
13. Hsieh, C.C., M. H. Yen, H. W. Liu, and Y. T. Lau. 2000. Lysophosphatidylcholine induces apoptotic and non-apoptotic death in vascular smooth muscle cells: in comparison with oxidized LDL. Atherosclerosis. 151: 481-491.
14. Kohno, M., K. Yokokawa, K. Yasunari, M. Minami, H. Kano, T. Hanehira, and J. Yoshikawa. 1998. Induction by lysophosphatidylcholine, a major phospholipid component of atherogenic lipoproteins, of human coronary artery smooth muscle cell migration. Circulation. 98: 353-359.
15. Rong, J. X., J. W. Berman, M. B. Taubman, and E. A. Fisher. 2002. Lysophosphatidylcholine stimulates monocyte chemoattractant protein-1 gene expression in rat aortic smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 22: 1617-1623.
16. Samanta, U., and B. J. Bahnson. 2008. Crystal structure of human plasma plate-activating factor acetylhydrolase. J. Biol. Chem. 283: 31617-31624.
17. Zalewski, A., C. Macphee. 2005. Role of LDL-associated phospholipase A2 in atherosclerosis: biology, epidemiology, and possible therapeutic targets. Arterioscler. Thromb. Vasc. Biol. 25: 923-931.
18. Ballantyne, C. M., R. C. Hoogeveen, H. Bang, J. Coresh, A. R. Folsom, L. E. Chambless, M. Myerson, K. K. Wu, A. R. Sharrett, and E. Boerwinkle. 2005. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study. Arch. Intern. Med. 165: 2479-2484.
19. Garza, C. A., V. M. Montori, J. P. McConnell, V. K. Somers, I. J. Kullo, and F. Lopez-Jimenez. 2007. Association between lipoprotein-associated phospholipase A2 and cardiovascular disease: a systematic review. Mayo Clin. Proc. 82: 159-165.
20. Packard, C. J., D. S. O'Reilly, M. J. Caslake, A. D. McMahon, I. Ford, J. Cooney, C. H. Macphee, K. E. Suckling, M. Krishna, F. E. Wilkinson, et al. 2000. Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group. N. Engl. J. Med. 343: 1148-1155.
21. Kiechl, S., J. Willeit, M. Mayr, B. Viehweider, M. Oberhollenzer, F. Kronenberg, C. J. Wiedermann, S. Oberthaler, Q. Xu, J. L. Witztum, et al. 2007. Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study. Arterioscler. Thromb. Vasc. Biol. 27: 1788-1795.
22. Stafforini, D. M., M. R. Elstad, T. M. McIntyre, G. A. Zimmerman, and S. M. Prescott. 1990. Human macrophages secrete platelet-activating factor acetylhydrolase. J. Biol. Chem. 265: 9682-9687.
23. Hakkinen, T., J. S. Luoma, M. O. Hiltunen, C. H. Macphee, K. J. Milliner, L. Patel, S. Q. Rice, D. G. Tew, K. Karkola, and S. Yla-Herttuala. 1999. Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase, is expressed by macrophages in human and rabbit atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 19: 2909-2917.
24. Elstad, M. R., D. M. Stafforini, T. M. McIntyre, S. M. Prescott, and G. A. Zimmerman. 1989. Platelet-activating factor acetylhydrolase increases during macrophage differentiation. A novel mechanism that regulates accumulation of platelet-activating factor. J. Biol. Chem. 264: 8467-8470.
25. Kolodgie, F. D., A. P. Burke, K. S. Skorija, E. Ladich, R. Kutys, A. T. Makuria, and R. Virmani. 2006. Lipoprotein-associated phospholipase A2 protein expression in the natural progression of human coronary atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 26: 2523-2529.
26. Tsimihodimos, V., S. A. Karabina, A. P. Tambaki, E. Bairaktari, G. Miltiadous, J. A. Goudevenos, M. A. Cariolou, M. J. Chapman, A. D. Tselepis, and M. Elisaf. 2002. Altered distribution of platelet-activating factor- acetylhydrolase activity between LDL and HDL as a function of the severity of hypercholesterolemia. J. Lipid Res. 43: 256-263.
27. Stafforini, D. M., L. W. Tjoelker, S. P. McCormick, D. Vaitkus, T. M. McIntyre, P. W. Gray, S. G. Young, and S. M. Prescott. 1999. Molecular basis of the interaction between plasma platelet-activating factor acetylhydrolase and low density lipoprotein. J. Biol. Chem. 274: 7018-7024.
28. Lavi, S., J. P. McConnell, C. S. Rihal, A. Prasad, V. Mathew, L. O. Lerman, and A. Lerman. 2007. Local production of lipoprotein-associated phospholipase A2 and lysophosphatidylcholine in the coronary circulation: association with early coronary atherosclerosis and endothelial dysfunction in humans. Circulation. 115: 2715-2721.
29. Caslake, M. J., C. J. Packard, K. E. Suckling, S. D. Holmes, P. Chamberlain, and C. H. Macphee. 2000. Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase: a potential new risk factor for coronary artery disease. Atherosclerosis. 150: 413-419.
30. Tselepis, A. D., and M. John Chapman. 2002. Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolase. Atheroscler. Suppl. 3: 57-68.
31. Kudo, I., and M. Murakami. 2002. Phospholipase A2 enzymes. Prostaglandins Other Lipid Mediat. 68-69: 3-58.
32. Holvoet, P., E. Macy, M. Landeloos, D. Jones, N. S. Jenny, F. Van de Werf, and R. P. Tracy. 2006. Analytical performance and diagnostic accuracy of immunometric assays for the measurement of circulating oxidized LDL. Clin. Chem. 52: 1-4.
33. Lopes-Virella, M. F., S. Koskinen, M. Mironova, D. Horne, R. Klein, C. Chassereau, C. Enockson, and G. Virella. 2000. Preparation of copper oxidized LDL for the measurement of oxidized LDL antibodies by EIA. Atherosclerosis. 152: 107-115.
34. Sui, B., P. Gao, Y. Lin, B. Gao, I. Lui, and J. An. 2008. Blood flow patterns and wall shear stress in the internal carotid arteries of healthy subjects. Acta Radiol. 49: 806-814.
35. Harloff, A., F. Albrecht, J. Spreer, A. F. Stalder, J. Bock, A. Frydrychowitz, J. Shollhorn, A. Hetzel, M. Schumaker, J. Henning, et al. 2009. 3D blood flow characteristics in the carotid artery bifurcation assessed by fl ow sensitive 4D MRI at 3T. Magn. Reson. Med. 61: 65-74.
36. Gazi, I., E. S. Lourida, T. Filippatos, V. Tsimihodimos, M. Elisaf, and M. D. Tselepis. 2005. Lipoprotein-associated phospholipase A2 activity is a marker of small, dense LDL particles in human plasma. Clin. Chem. 51: 2264-2273.
37. Blake, G. J., N. Dada, J. C. Fox, J. E. Manson, and P. M. Ridker. 2001. A prospective evaluation of lipoprotein-associated phospholipase A2 levels and the risk of future cardiovascular events in women. J. Am. Coll. Cardiol. 38: 1302-1306.
38. Cushing, G. L., J. W. Gaubatz, M. L. Nava, B. J. Burdick, T. M. Bocan, J. R. Guyton, D. Weilbaecher, M. E. DeBakey, G. M. Lawrie, and J. D. Morrisett. 1989. Quantitation and localization of apolipoproteins [a] and B in coronary artery bypass vein grafts resected at re-operation. Arteriosclerosis. 9: 593-603.
39. Papagrigorakis, E., D. Iliopoulos, P. J. Asimacopoulos, H. J. Safi, D. J. Weilbaecher, K. G. Ghazzaly, M. L. Nava, J. W. Gaubatz, and J. D. Morrisett. 1997. Lipoprotein(a) in plasma, arterial wall, and thrombus from patients with aortic aneurysm. Clin. Genet. 52: 262-271.
40. Mannheim, D., J. Herrmann, D. Versari, M. Gosyl, F. B. Meyer, J. P. McConnell, L. O. Lerman, and A. Lerman. 2008. Enhanced expression of Lp-PLA and lysophosphatidylcholine in symptomatic carotid atherosclerotic plaques. Stroke. 39: 1448-1455.
41. Ghosn, M.G., M. Leba, A. Vijayananda, P. Rezaee, J. D. Morrisett, and K. V. Larin. 2009. Effect of temperature on permeation of low density lipoprotein particles through human carotid artery tissues. J. Biophotonics. 2: 1-9.